BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 1897551)

  • 1. Comprehensive drug-use evaluation program in a health maintenance organization.
    Cotterell CC; Dombroske L; Fischermann EA
    Am J Hosp Pharm; 1991 Aug; 48(8):1712-7. PubMed ID: 1897551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of generic screening criteria for clinical interventions that link prescribing to credentialing.
    Mustion AL; Sobotka J
    Hosp Pharm; 1991 Nov; 26(11):968-72, 1015. PubMed ID: 10114824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing drug-usage evaluation to meet Joint Commission requirements.
    Peroutka JA
    Pharm Pract Manag Q; 1996 Jul; 16(2):26-35. PubMed ID: 10161608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revising a drug information center quality assurance program to conform to Joint Commission standards.
    Moody ML
    Am J Hosp Pharm; 1990 Apr; 47(4):792-4. PubMed ID: 2321654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to develop a successful DUE (drug usage evaluation) program: experience of a teaching medical center.
    Cheung MO
    Hosp Formul; 1994 Feb; 29(2):137-9, 142-3, 145. PubMed ID: 10131876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Documenting concurrent clinical pharmacy interventions.
    Haslett TM; Kay BG; Weissfellner H
    Hosp Pharm; 1990 Apr; 25(4):351-5, 359. PubMed ID: 10104389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW; Keith TD; Foster MT
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simplistic approach to establishing drug usage/quality assurance programs.
    Adachi W
    Hosp Pharm; 1990 Jun; 25(6):541-4, 546-50, 555-9. PubMed ID: 10104830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A system for documentation of pharmacist interventions with incorporation into performance and quality improvement plans.
    Brown BL; Williamson SE
    Hosp Pharm; 1993 Nov; 28(11):1083-4, 1086-8. PubMed ID: 10130385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meeting JCAHO drug usage evaluation requirements in a small hospital.
    Moline KA
    Hosp Pharm; 1990 May; 25(5):486-8, 492. PubMed ID: 10104827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1988 Joint Commission survey in a community hospital.
    Guharoy S; Barajas M; McGalliard J; Aguer T
    Hosp Pharm; 1989 Apr; 24(4):287-9. PubMed ID: 10293284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assuring the quality of a clinical pharmacokinetics service.
    Waller DJ; Smith SR
    Am J Hosp Pharm; 1986 Sep; 43(9):2184-8. PubMed ID: 3766569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target drug monitoring: a cost-effective service provided by staff pharmacists.
    Chrymko MM; Meyer JD; Kelly WN
    Hosp Pharm; 1994 Apr; 29(4):347, 350-2. PubMed ID: 10133463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacy-coordinated process for evaluating physician drug prescribing.
    Peterson CD; Goldberg DE
    Am J Hosp Pharm; 1989 Sep; 46(9):1787-91. PubMed ID: 2508469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of medication-use indicators by the Joint Commission on Accreditation of Healthcare Organizations.
    Nadzam DM
    Am J Hosp Pharm; 1991 Sep; 48(9):1925-30. PubMed ID: 1928134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peer review as a quality assurance mechanism in three pharmacist-run medication-refill clinics.
    Cram DL; Stebbins M; Eom HS; Ratto N; Sugiyama D
    Am J Hosp Pharm; 1992 Nov; 49(11):2727-30. PubMed ID: 1471637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality improvement in the use of medications through a drug use evaluation service.
    Stevenson JG; Bakst CM; Zaran FK; Rybak MJ; Smolarek RT; Alexander MR
    Top Hosp Pharm Manage; 1992 Oct; 12(3):47-56. PubMed ID: 10128747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality assurance to quality improvement: measuring and monitoring pharmaceutical care.
    Angaran DM
    Am J Hosp Pharm; 1991 Sep; 48(9):1901-7. PubMed ID: 1928130
    [No Abstract]   [Full Text] [Related]  

  • 19. The JCAHO Agenda for Change: what changes in pharmacy and P & T activities do you need to prepare for in 1994?
    Doherty EC
    Hosp Formul; 1994 Jan; 29(1):54-6, 58-60, 64 passim. PubMed ID: 10131267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-usage evaluation and the patient-care pharmacist: a synergistic combination.
    Gayman J; Tapley DJ
    Top Hosp Pharm Manage; 1991 Jul; 11(2):31-43. PubMed ID: 10128633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.